The company wants to leverage on its capabilities and global leadership position in Pyridine, Picoline and Diketene chemistries
Croda has acquired a controlling majority 95.6% of Parfex’s outstanding shares
Company has signed definitive agreement to buy IM Chemicals, a leading provider of specialty chemical products serving the pharmaceutical, coatings, and fuel & lubricant markets
The cutting-edge laboratory will complement the existing network of research and application centers dedicated to Arkema’s Coating Solutions so that to Arkema’s performance additives
These vaccine doses will be manufactured and stockpiled by the company from August-December 2021
The acquisition will help the company to expands its operations in agrochemicals and oil & gas thereby providing incremental value to its stakeholders
The company reported total income of Rs.634.79 crores during the 12 months period ended March 31, 2021
Pegfilgrastim has estimated annual sales of USD 3.66 billion in the U.S. (IQVIA MAT December 2020).
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Production line at Lonza’s site in Geleen will complement the existing production network and support the manufacture of up to an additional 300 million doses per year
For undertaking production, the company has been provided a Rs. 65 crore grant by the centre and Rs. 94 crore from the government of Maharashtra
Production will start in 2022
The company also plans to supply five products to its parent and global affiliates
The acquisition enables Azelis to gain a strong position in the growing and non-cyclical markets of flavors and fragrances in the Americas
The acquisition enhances the portfolio of IMCD China which serves the pharmaceutical, food and nutrition, plastics, and personal care industries
With this acquisition, Aceto now provides customers enhanced support throughout the drug development process and greater access to expanded North American manufacturing, particularly for APIs and advanced intermediates
Company is developing two projects that contribute to further developing the Porvoo refinery in Finland into renewable hydrogen and CO2 utilisation as well as advanced biofuels production from lignocellulosic wastes and residues.
The facility is scheduled to come into operation in March 2024
It reported total income of Rs.31.91 crores during FY 2020-21
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
Subscribe to our newsletter & stay updated.
_195_291.jpg)
